Carregant...
WBRT for brain metastases from non-small cell lung cancer: for whom and when?—Contemporary point of view
The incidence of brain metastases (BM) is estimated between 20% and 40% of patients with solid cancer. The most common cause of this failure is lung cancer, and in locally advanced non-small cell lung cancer (NSCLC) BM represent a common site of relapse in 30–55% cases. The basic criteria of therape...
Guardat en:
| Publicat a: | J Thorac Dis |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
AME Publishing Company
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8182552/ https://ncbi.nlm.nih.gov/pubmed/34164217 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd-2019-rbmlc-06 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|